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Regulation of cell behavior in response to nanoscale features has been the focus of much research in recent years and the successful
generation of nanoscale features capable of mimicking the natural nanoscale interface has been of great interest in the field of biomaterials
research. In this review, we discuss relevant nanofabrication techniques and how they are combined with bioengineering applications to
mimic the natural extracellular matrix (ECM) and create valuable nanoscale interfaces.
© 2017 TheAuthors. Published by Elsevier Inc. This is an open access article under the CCBY license (http://creativecommons.org/licenses/by/4.0/).Key words: Nanofabrication; Interface; Biomaterials; Extracellular matrixCell behavior is regulated by soluble factors, cell–cell
interactions and cell–extracellular matrix (ECM) interactions.
Despite soluble chemical-based regulation of cell behavior tradi-
tionally being a topic of great interest, many researchers are now
focusing on regulating cell behavior using physical cues associated
with the nanoscale features of the ECM. It is well understood that
cells respond to these nanoscale features and that they have the
capacity to influence many cellular characteristics frommorphology
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features is a rapidly growing research area.1–3
As the interest in regulating nanoscale features and the
nanoscale interfaces arising from these features has heightened, a
range of nanofabrication techniques have been developed and
used in the generation of physical cues capable of enhancing key
characteristics of stem cells, such as their ability to differentiate
down particular lineages. Techniques centered around lithography,
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Figure 1. Integrin adhesion receptors link the extracellular matrix (ECM) to the actin cytoskeleton. The incorporation of ECM proteins and growth factors into
biomaterials, allows for cells to respond to such materials via integrin binding. Following integrin-based binding of cells to the materials, signals can be
transmitted to the nucleus via actin filaments.
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can then be used as substrates for cell culture. What has been
particularly striking about lithographic nanofabrication is that
despite it primarily being a 2D process and thus cells are tested as
2D cultures, such surfaces are capable of generating similar levels
of cell differentiation to that observedwhen cells are cultured in 3D
ECM gels.4,5 Although this initial discovery of the benefits of
lithographic techniques is very promising, we are now seeing
further advances in the use of lithography-based nanofabrication as
it is being employed to spatially regulate cellular differentiation.
Such spatial regulation of cellular differentiation is of prime
importance as the progression in the research into nanoscale
interfaces leads us out of in vitro testing and into in vivo testing and
ultimately applications of these interfaces in the clinic.6,7 Similarly,
research into materials made via electrospinning has also shown that
these interfaces are of potential clinical value, in that they have been
shown to enhance bone formation without the problem of
inflammation.8 Thus, it is becoming increasingly clear that
manipulation of the nanoscale interface is of clinical significance.
Despite there being a broad appreciation of the diverse range of
responses cells can make to physical nanoscale features, there is an
increasing interest in using biomaterials to specifically mimic the
nanoscale interface of the native microenvironment.9,10 Cells
respond to signals from the nanoscale environment associated with
the ECM, including those coming from ECM proteins such as
fibronectin, and also growth factors (GFs). This ability of cells to
respond to ECM proteins has led to an increased interest in
incorporating them into biomaterial research. This has consequently
led to a new generation of biomaterials with nanoscale interfaces
closer to those found in the ECM or, indeed, engineering ECM
components as the nanoscale features.11–14 This incorporation of
ECM proteins has also opened up new avenues for research into cellbehavior regulation in response to nanoscale interfaces, as not only
do these ECMproteins have nanoscale features, there is also scope to
engineer biological complexity through protein–protein
interactions.15,16 For example, it is now understood that fibronectin
has a growth factor binding domain, which can be constitutively
exposed when fibronectin is adsorbed onto certain polymers, e.g.
poly (ethyl acrylate) (PEA), providing a means for tethering growth
factors to substrates and therefore adding additional nanoscale
features to those already existing due to the presence of fibronectin.17
This review will discuss current progress in understanding
and exploiting cell–nanointerface interactions.
Nanofabrication in the generation of nanoscale interfaces
Lithography nanofabrication in the creation of nanoscale interface
Control of cell behavior at the nanoscale has led to development
of suitable nanoscale interfaces and the development of techniques
focused on creating nanoscale features and patterns (Table).6 The
generation of surfaces featuring nanotopography relies primarily on
the processes of lithography (pattern transfer).18
One of the most high-resolution nanolitographical techniques is
electron beam lithography, where an electron beam is focused on to
substrates coated in electron sensitive resist. The resist can then be
developed and etched to provide the lithographical step– commonly
used now is reactive ion etch, or dry etch.19 It has been shown that it
is possible to produce etches of 5-7 nmon surfaces, using an electron
beam of 5 nm diameter.20 Electron beam lithography typically
writes onto silicon wafers as it is a semiconductor industry driven
technique. However, nanoimprint lithography can then be used to
produce polymeric replicas by e.g. injection molding and these
replicas have been used to understand cell response.21–24 Further,
electron beam lithography has also been used to successfully ablate
Table
Summary of materials used in nanofabrication techniques.
Technique Materials References
Electron Beam & Nanoimprint Lithography 1. Polycarbonate 1. Hart et al (2007)
2. PMMA 2. Chou et al (1997);
Biggs et al (2009)
3. Polycaprolactone 3. Nie et al (2008)
4. Polyethylene terephthalate 4. Antonini et al (2016)
5. Poly(ethylene glycol) 5. Rundqvist et al (2006)
6. Organosilane Self-Assembled Monolayers 6. Zhang et al (2005)
Photolithography 1. Poly(ethylene glycol) 1. Koh et al (2002)
2. Poly-N-isopropylacrylamide 2. Albrecht et al (2005)
3. Chitosan 3. Karp et al (2006)
4. Biohybrid hydrogels
(e.g. PEG-based hydrogels modified
with peptide Arg-Gly-Asp (RGD)
4. Revzin et al (2003)
5. Titanium dioxide 5. Qiu et al (2016)
X-ray Lithography 1. polyurethane 1. Diehl et al (2005)
2. Poly (ethylene glycol) 2. Kim et al (2010)
Electrospinning 1. Polycaprolactone 1. Ganesh et al (2014)
2. Chitosan 2. Lotfi et al (2016)
Molecular self-assembly 1. (RADS) motif polymers 1. Zhang et al (1999)
2. Collagen 2. Aravamudhan et al (2016)
3. Peptide-amphiphiles (PAs) 3. Yu et al (1998)
4. Fibronectin 4. Llopis-Hernández et al (2016);
Rico et al (2016)
3H. Donnelly et al / Nanomedicine: Nanotechnology, Biology, and Medicine xx (2017) xxx–xxxprecise patterns into self-assembled monolayers (SAMs).25 Highly
regarded for its precision, electron beam lithography in conjunction
with self-assembled monolayers is now being used for a range of cell
studies, despite being a slow and costly method of fabrication.26,27
Other types of lithography used for nanofabrication of
biomaterials are X-ray lithography and photolithography, where
softX-rays ofwavelengths between0.4 and5 nmorUV light is used
as the radiation source.19,28,29 Soft X-rays and lithography have been
used in the generation of biomimetic nanoscale interfaces with
substratum features resembling the native basement membrane of
the cornea, and has been used in studies focused on the use of
biomaterials in corneal prosthesis development.29–31 X-ray lithog-
raphy has also been used in the generation of nanoscale biohybrid
gels composed of PEG-based hydrogels modified with peptide
Arg-Gly-Asp (RGD) and also titanium dioxide.6,32 In addition,
X-ray lithography has been used to produce anisotropically
nanofabricated substratum (ANFS) formed from scalable, biocom-
patible polyethylene glycol (PEG) hydrogel arrays, which have been
used in the generation of macroscopic regions cardiac tissue
constructs.33 The benefit of using X-ray lithography with the PEG
hydrogel arrays is that it allows for the production of constructs that
are structurally similar to the native myocardial environment, and
that are also chemically similar, allowing maintenance of electro-
physiological function.34
As touched on above, for biomaterials and tissue engineering
research, polymers are of much greater interest than
semiconductor-based materials such as silicon as they are
biocompatible, flexible, processable and amenable to surface
chemistry applications; in fact, chemical modifications of polymers
are gaining increasing interest as a means of modulating the ECM
and cell responses to it.7,11 Thus, it is of significance that simply
heating thermoplastic polymers to above glass transition temperature
(Tg) and applying the pattern (in silicon or as a metalized shim forexample) can produce high-fidelity (down to 5 nm) patterns in a
wide range of polymers. We note that if the user is not concerned if
the pattern is imprinted into polymer in the inverse, the original
silicon master can be used as a stamp. However, sputtering and
electroplating the master with nickel and then removing the master
creates a negative against which polymer can be imprinted as per the
originally defined pattern. Imprinting strategies from simply
applying pressure by hand in low Tg polymers such as
poly(caprolactone) (PCL) to injection molding for high throughput
manufacture are now commonly used.35
Advances in nanofabrication over the last decade havemeant that
it has been possible to produce a diverse range of nanoscalematerials
able to be used in the generation of nanointerfaces for
bioengineering.36 Many cell types have been used with these
interfaces, but perhaps the best characterized are mesenchymal stem
cells (MSCs).Due to their interactionwithmaterials interfaces,MSC
differentiation can be guided down different lineages, offering
platforms for their regulation. Results showed that osteoprogenitors
andMSCs cultured on disordered (but not random) topographies had
raised levels of osteopontin and osteocalcin expression, suggesting
that this particular material could be a candidate for bone-producing
nanointerfaces. Subsequently, disordered nanotopographies have
been produced into orthopedic-relevant materials, such as titanium,
and shown to enhance bone formation in vitro and in vivo.37,38
From this early work, production of biomaterials mimicking the
nanoscale interface has been of great interest. For example, it could
be noted that collagen type X, produced by cells during
endochondral ossification and in large fracture repair, has a
nanoscale pattern of controlled disorder – similar to the electron
beam fabricated disordered surface features.39 In 2016, work was
presented illustrating the use of photolithography to generate
titanium dioxide nanotopographies, formed from nanorod arrays,
that could be used in conjunction with smooth surfaces to spatially
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promise for the future of nanoscale biomaterial development, as they
support the idea of production of materials with variation at the
nanoscale interface, closely mimicking naturally-occurring nano-
scale features that can recapitulate biological complexity e.g. at the
bone/ligament interface. Further work in 2016 from Antonini et al
has also shown the potential for the use of nanofabricated
biomaterials to create biointerfaces. Also focused toward enhancing
the osteogenic potential of MSCs, Antonini et al presented work
using lithography-fabricated polyethylene terephthalate nanograt-
ings, demonstrating their capacity to also enhance osteogenic
differentiation of MSCs relative to flat controls.40
Nanoscale topography has been used to help elucidate
cell-osteogenesis mechanisms. As cells adhere, they form large
multi-protein complexes termed cell adhesions. Adhesions contain
ECM adhesive strata containing integrins, a signaling strata
containing e.g. focal adhesion kinase (FAK), a force transduction
layer containing e.g. vinculin and an actin regulatory layer
that localizes adhesions to the contractile microfilament
cytoskeleton.41 Mechanical contraction is important as adhesions
require both integrin anchorage to the ECM and force application in
order to grow; and the longer adhesions become the more signaling
that can be potentiated from the growth of the signaling strata. Upon
integrin engagement, G-proteins are activated, including Rho, which
drives actin/myosin sliding and hence cytoskeletal contraction. The
growth of adhesions is critical for osteogenesis as osteoblasts are
high-tension phenotypes that use super-mature adhesions (N5 μm
long) to stabilize the contraction.9,42 Nanoscale topographies that
induce osteogenesis from MSCs tend to drive cell adhesion and it
seems likely that induction of endogenous vitronectin production
rather than fibronectin production is important (matrix proteins and
integrinswill be discussed in detail in the next section).43 Vitronectin
better permits integrin bridging, adhesion and elongation allowing
for breaks in the integrin strata through bridging in the force
transduction layer.44
It is apparent that there is an ever-expanding future for the use
of bioengineered nanoscale interfaces for the generation of
biomaterials suitable for use in the clinic. For example,
interesting results are being shown when stem cells including
MSCs, induced pluripotent stem cells (iPSCs) and embryonic
stem cells (ESCs) are cultured on nanoscale topographies. It has
been observed that culturing ESCs on ridged nanotopographies
induces increased cell alignment and elongation, but also reduces
cell proliferation.45 Kingham et al showed that ESCs cultured on
disordered nanotopograpies expressed MSC-like marker profile,
and that it is possible to overcome challenges in regenerative
medicine associated with the production of reproducible
platforms for ESC differentiation.46 Further, work from Kong
et al showed that it is possible to regulate gene expression of the
Oct4 pluripotency gene in response to nanotopographical cues,
which represents a milestone in human ESC research.47
Nanofabrication techniques to recapitulate the ECM
nanoscale interface
The ECM is an intricate meshwork of protein fibers such as
those of collagen and elastin, ranging from 10 to 300 nm in
diameter (Table).48,49 The interwoven mesh is then also coveredwith nanoscale adhesive proteins including fibronectin, meaning
that the ECM has a porous, nanoscale topography. In addition to
these common features, the structure of bone comprises further
hydroxyapatite crystals, highlighting the importance of the
nanoscale interface in bioengineering. In an attempt to mimic the
woven, fibrous nature of the ECM, biomaterials research
employs techniques such as electrospinning and molecular
self-assembly as methods of producing more ECM-like features
compared to lithographical protocols (Figure 1).27,50 Use of
these techniques to generate nanostructured biomaterials is
finding particular importance in MSC and orthopedic research.51
Electrospinning allows for the controlled deposition of
polymer fibers on to a substrate, and is now a commonly used
technique in the production of biomaterials. It is one of the most
versatile methods for the generation of nanoscale fibers similar in
morphology and dimension to the native ECM.52–54 For
example, it has recently been reported that incorporation of
nanohydroxapatite into PCL composite scaffolds has the ability
to increase protein adsorption capacity of scaffolds, and also to
enhance MSC proliferation and osteogenic differentiation. PCL is
broadly used in such studies as it can be used to form composite
scaffolds as it is biodegradable, has known mechanical properties
and providing contrast capabilities that would allow the regener-
ative healing processes to be monitored in vivo.53
Work from Lotfi et al in 2017 has shown that chitosan-
nanoelectrospun collagen membranes are also able to increase
MSC proliferation and osteogenic differentiation compared to
solid wall surfaces.55 This work elegantly demonstrates the careful
pairing of the non-toxic, non-immunogenic, biocompatible, and
biodegradable properties of chitosan with electrospinning. Use of
this biomaterial was shown to increase bone formation in vivo,
while causing no increased levels of inflammation (Figure 2).
Molecular self-assembly is a second type of nanofabrication
gaining popularity as a result of it being naturally ubiquitous in
biological systems, as well as its simplicity.56 This method for
the synthesis of nanostructures is based around a spontaneous
association of molecules under equilibrium conditions into
structurally stable aggregates, and is used to fabricate novel,
supramolecular architectures. Work on this method of nanofab-
rication has progressed considerably in the last three decades,
and has shown that a variety of peptides can be designed to
self-assemble into a monolayer on surfaces, allowing cells to
adhere and respond appropriately.57,58
Potential for the use ofmolecular self-assembly in generation of
the nanoscale interface was highlighted in work by Zhang et al in
1999, where it was shown that self-assembly of oligopeptides
containing cell adhesion motifs could be used to fabricate a range
of surface patterns.59 These surface patterns could then be used to
drive spatially regulated cell adhesion, a valuable feature in
biomaterials where materials can be used as tools to help
understanding of cell mechanisms. The function of these
biomaterials is largely attributed to the presence of a C-terminal
cysteine residue on the oligopeptide, which allows the peptide to
covalently link to a bioinert gold-coated surface. Easy combination
of a bioinert surface with oligopeptides capable of molecular
self-assembly illustrates the vast potential for use of
molecular-self-assembly in the generation of biocompatible
nanoscale interfaces.
Figure 2. The use of molecular self-assembly and electrospinning in the generation of ECM-mimetic biomaterials. Molecular self-assembly involves the
spontaneous self-assembly of protein structures and is often used in the generation of nanoscale ECM-mimetic biomaterials. Similarly, electrospinning is used to
generate fibrous nanoscale structures, also capable of mimicking the nature of the natural ECM.
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that it is possible to use it for the production of small diameter
nanofibers in the lowest end of the range of the natural ECM
component collagen, a clear advantage over other nanofabrica-
tion techniques.60,61 More recently, we have seen molecular
self-assembly used similarly to aforementioned nanofabrication
techniques, in that it is also being used in studies showing its
capacity to regulate MSC fate with potential for use in
orthopedics.62 Earlier this year, Aravamudhan et al published
work showing that molecular self-assembly of collagen to form
collagen nanofibers on a natural polymeric microporous
structure could both enhance osteogenic differentiation of
MSCs and enhance the biocompatibility of the biomaterial
when subcutaneously implanted in mice.
Recently, an example of using materials as tools utilized
supramolecular self-assembly of nanofibers in hydrogels of
different stiffness.63 It has been shown that mimicking tissue
stiffness drives stem cell differentiation.2 However, many
hydrogels require crosslinking, coating and functionalization to
change stiffness and allow cell interactions. New hydrogels have
been designed from peptide nanofibers whereby stiffness was
controlled using fiber density and no functionalizing or coating
was required to permit cell adhesion. Such a clean system
allowed for metabolomic comparison between MSC differenti-
ation to express neural markers, chondrogenic markers and
osteogenic markers at stiffnessess of 1, 15 and 32 kPa
respectively. The lack of potential metabolite background from
the nanofiber networks allowed identification of lineage
specifying metabolites that, free from use of the gels, could be
used to drive targeted differentiation.64 This demonstrates
potential for new biomaterials in drug discovery.
Although collagen is a commonly researched protein in the
area of molecular self-assembly, the study of other ECM proteins
such as fibronectin (FN) and their self-assembly is also gaining
attention. For example, studies have shown that FN can
spontaneously form nanoscale networks in response to adsorp-tion on PEA.65 In addition, data have been published showing
FN nanoscale features induced as a response to poly(methyl
acrylate) (PMA) and PEA, promote maintenance of MSC
stemness, rather than lineage commitment. This work has been
key in highlighting the future for the use of molecular
self-assembly in the generation of nanoscale interfaces, which
could be used in MSC niche design.Roles of peptides at the nanoscale interface
of the extracellular matrix
The ECM is a dynamic network, supplying microenviron-
ments with reservoirs of GFs and peptides, as well as integral
structural support for organs, tissues and performing key roles in
the stem cell niches. As well as looking toward topographical
inspiration from the ECM, key signals from this micro/
nanoenvironment are being incorporated into biomaterials;
these include insoluble extracellular matrix macromolecules
and diffusible or soluble molecules, such as GFs.3,66
The ECM is extremely heterogeneous and tissue specific.
However, there are three major classes of insoluble macromol-
ecules: (1) structural proteins, such as collagen, laminin and
elastin, (2) fibrous glycoproteins including fibronectin and
vitronectin and (3) glycosaminoglycans (GAGs) such as keratin,
hyaluronic acid and chondroitin sulfate, which are hydrophilic
molecules with roles in buffering and cell adhesion.67 The
secreted ECM exists as a network of these proteins acting as a
nanoscale structure to support cells and provide an actively
instructive interface to guide behavior as discussed above. Each
of these proteins contains a plethora of binding, attachment and
signaling capabilities that exist in numerous combinations of
isoforms, ratios and topographical arrangements to produce the
precise environment. In turn this leads to a wealth of molecular
mechanisms that propagate this information into signals to cells
to form complex tissues.
Figure 3. Integrins presented in synergy with growth factors. (A) Structure of fibronectin, showing location of major binding sites. The integrin binding region of
FN is FNIII9-10, which lies adjacent to FNIII12-14, the growth factor binding region. (B) AFM images (phase magnitude) of FN adsorbed on material
substrates. The scale bar is 0.5 μm. FN adsorption results in a self-assembled FN nanonetwork at the material interface of PEA but not PMA, this promotes
synergystic signaling through integrins and growth factor receptors. (Reprinted (adapted) with permission from 76 Copyright 2015 American Chemical Society.)
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dimeric glycoprotein with two subunits of ~250 kDa each,
linked by intramolecular disulfide bonds. Each subunit contains
three modular repeating units, type I, II and III, which mediate
interactions with other FN molecules (FNI1-5 and FNIII1-2), other
ECM components or integrins (FNIII9-10), and GFs (FNIII12-14)
(Figure 3). Integrin α5β1 is well characterized as the primary
receptor for FN; it contains an arg-gly-asp (RGD) site located in
the type III10 repeat which has a three-dimensional presentation
containing integrin binding pockets. Therefore, multiple integ-
rins such as αvβ3 also bind the RGD site, but they remain
uninfluenced by the presence of an additional synergistic
sequence from the FNIII9 repeat, Pro-His-Ser-Arg-Asn
(PHSRN), that is required for full adhesive activity from the
α5β1 receptor, enhancing the affinity of the integrins for the
RGD loop over forty-fold.68,69
Attempts to engineer ECM-derived adhesive peptides at the
nanoscale interface to increase substrate bioactivity have focused
on using recombinant fragments of the FN RGD domain
adsorbed onto synthetic or natural non-fouling, non-absorbent
materials. Many studies have demonstrated integrin-mediated
effects on cell adhesion and migration as a result of RGD
incorporation onto a range of materials such as alginate
hydrogels, silk films and synthetic polymers.70–72 However,
the bioactivity of these materials is significantly lower than when
the full protein is used. Garcia's group has engineered
recombinant FNIII7-10, a 39 KDa fragment of native FN modules
7-10 containing both the RGD and PHSRN synergy sites. Thefragment maintains the native conformational spacing between
the sites, as the structural orientation of these two domains is
essential for synergistic effects, and increases in distance have
been shown to lead to complete abrogation of α5β1 binding, cell
spreading and signaling.73,74 This FNIII7-10 fragment was
immobilized to a support surface, non-adhesive albumin, at
controlled ligand densities. Cells adhered to these functionalized
substrates, spread and assembled focal adhesions containing α5β1,
vinculin and talin, and this effect was abrogated upon blocking with
integrin-specific antibodies where cell adhesion was completely
eliminated.74,75 The group also recently translated this fragment to
coat stainless steel fixation screws in osteoporotic rats, implants
coatedwith the FNIII7-10 enhanced bone-screw fixation by over 50%
and bone-implant ingrowth by 30% after 3 months.76
Work from the Spatz group has also been particularly
revealing, reporting that focal adhesion formation is dependent
on the ability to ligate multiple RGD ligands. Using colloidal
patterning and placing RGD groups on the resultant topographies
has shown that RGD subunits need to be less than 70 nm apart
for integrin gathering into mature focal adhesion to occur.77–79
The gathering of integrins allows formation of the signaling
strata driving cytoskeletal tension. This allows the cells to
manipulate the ECM, in effect gathering RGDs to facilitate
further integrin gathering, growing the adhesion – potentially to
form super mature adhesions capable of stabilizing the high
degree of intracellular tension required for MSC osteogenesis.43
Native FN is a globular protein, and its unfolding leads to
exposure of these cryptic binding sites for integrin and also GF
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the fibrillar networks that the ECM is comprised of. The process
of unfolding is usually initiated by integrins binding to FN
dimers, which causes FN self-association through exposure of
the N-terminal assembly domain, and this instigates contractile
forces in the cell to expose more binding sites.80 However, it has
recently been observed that certain polymeric materials can drive
FN unfolding without cells.11
When testing polymer-based cell-free systems, it was
observed that unfolding spontaneously arises when FN is
adsorbed onto PEA surfaces, but not on control polymers
(such as the closely related PMA7,11,12,81). Simple physical
adsorption of FN onto PEA leads to the molecular assembly of a
physiological-like network of fibrils, exposing the cryptic
binding sites of the FN molecule and this system has been
shown to enhance biological activities, for example myogenic
differentiation of murine C2C12 myoblasts (Figure 3).82
Another critical ECM protein is type I collagen, the most
abundant protein in bone, where molecules form highly
organized 3-dimensional scaffolds for cells. The primary
collagen-binding integrin is α2β1 which recognizes the hex-
apeptide GFOGER motif. 83 Collagen scaffolds are
well-documented to induce osteogenesis of MSCs and matrix
mineralization in vitro. However, recent efforts have focused on
increasing the poor mechanical strength of collagen-based
scaffolds for orthopedic applications.84–86 In vivo collagen
fibers exist as a highly cross-linked network; by mimicking this
process in-situ collagen cross-linking can be achieved, with one
study subsequently mineralizing the scaffold by incorporating a
composite of catecholamine's and calcium ions that form CaCO3,
increasing the Young's modulus to near that of cancellous bone.87
However, we note that a caveat with many cross-linking strategies
is that many agents used are cytotoxic. Collagen scaffolds, for
these limitations, are now more frequently incorporated into
multi-material implants as GF carriers.88,89Incorporation of growth factors in the nanoscale interface
GFs are critical biological signals that regulate cell growth,
stem cell differentiation and tissue healing. In developmental
biology, GFs co-ordinate cell differentiation and tissue organi-
zation, showing their large potential in regenerative medicine.90
The ECM acts as a reservoir for GFs as most ECM proteins and
GFs have reciprocal binding sites, allowing for GF
sequestration.91 The localized ECM can therefore regulate GF
signaling intensity and duration, and control spatial and temporal
GF signaling. Many engineering strategies attempt to functio-
nalize biomaterials to mimic this combinatorial ECM-GF-cell
nanointerface inspired by native GF interactions.92,93
Traditional applications of GFs in tissue engineering involve
solubilization of the GF in the cell growth media of MSC
cultures, but not only does this require supraphysiological
concentrations of the GF, it also does not permit the
spatiotemporal control of in vivo GF presentation.94,95 Introduc-
ing GF carriers such as ECM GF-binding domains, enables
tethering of the GF to the cell–material interface and thereby
increases local bioavailability to cells. Further to this, GFreceptors (GFRs) and integrins are able to form signaling
complexes, the localization of integrin-binding and GF-binding
domains onECMproteins can therefore drive enhanced synergistic
signaling to control cell behavior.7,15,96,97 In simple terms,
ECM-GF complexes provide highly targeted and amplified
(through receptor co-localization) signals to the cells (Figure 1).
Approaches to functionalize GFs at the material–cell
interface aim to control the release and spatial orientation of
these GFs. However, emerging methods each pose their own
individual drawbacks, with each GF also bringing its own unique
properties for effective delivery. Upon covalent immobilization
to a substrate, epidermal growth factor (EGF) was shown to
increase cell activation compared to passive physical
adsorption.98 Since this study many more have focused on
covalently modifying material interfaces. Fan et al 2007, used a
poly(methyl methacrylate)-graft-poly(ethylene oxide)
(PMMA-g-PEO) comb polymer system to covalently tether
EGF in controlled physiological-like concentrations. When
compared to saturated GF concentrations they found a significant
increase in cell survival and spreading. By controlling GF
spacing they were able to either restrict or support EGF receptor
(EGFR) homodimerization, while the covalent binding inhibited
receptor internalization thereby potentiating sustained EGFR
signaling.96 However, it must be considered that some GFs
require internalization for function, or some, such as vascular
endothelial GF (VEGF), act through a chemotactic gradient.99
The nature of covalent bonding of GF also has the potential to
disrupt GF conformation or bind it such that it is not in
physiological orientation.
Recently, it has been elucidated that the FN 12th and 14th
type III repeat is a highly promiscuous GF binding domain; this
domain has thus been the focus of approaches to tether GFs at the
material interface. The FNIII12-14 repeat binds VEGF/
platelet-derived GF (PDGF), fibroblast GF (FGF) and transform-
ing GF-β (TGF-β) family GFs with high affinity.13 The close
proximity of this GF binding-domain to the FNIII9-10
integrin-binding domain promotes co-localization of GFR and
integrins, leading to increased cross talk and synergistic cell
signaling.7 One study exploited this by generating a recombinant
FN fragment containing the FN III9-10 and III12-14 repeats only,
which were then covalently immobilized into a fibrin matrix.
Here they showed stimulation with solutions containing PDGF
and the FNIII9-10/FNIII12-14 fragment significantly enhanced
GF-induced proliferation and migration of MSCs when com-
pared to fragments containing only the FNIII 9-10 or FNIII 12-14
fragment, suggesting synergistic effects between the GF and
FNIII9-10/FNIII12-14-mediated integrin signaling.
13
Another recent study exploited the material-driven fibrillo-
genesis (molecular self-assembly) effects of the polymer PEA to
provide physiological presentation of GFs.7 Spin-coated PEA
surfaces were used to drive FN nanonetwork organization after
physical adsorption of the protein. Network formation exposes
the FN binding sites allowing tethering of the GF bone
morphogenic protein-2 (BMP-2) to the FNIII12-14 domain,
while simultaneously exposing FNIII9-10 to promote integrin
engagement and co-signaling. Robust osteoblastic differentiation
of MSCs was observed, molecular and genetic analysis alongside
co-immunoprecipitation and of the BMP-2 receptor (BMPR1a)
8 H. Donnelly et al / Nanomedicine: Nanotechnology, Biology, and Medicine xx (2017) xxx–xxxwith integrin β1 confirmed osteogenesis was driven through
enhanced canonical BMP-2 signaling as a consequence of a
synergistic occupancy of GFRs and integrins. Upon implantation
into a non-healing bone defect in mouse this material-based
approach was able to drive full tissue regeneration.7
Compared to soluble administration of GFs, systems that
engineer GFs to the material interface, including covalent protein
binding, have been shown to be more effective in controlling cell
fate and behavior at the nanoscale interface. However, these
technologies do not exploit the synergistic effects of integrins
and GFRs (Figure 3). Both Martino et al, 2011 and
Llopis-Hernandez et al, 2016, target integrins and GFRs in
synergy by exploiting native ECM components.7,13Future perspectives
The current literature demonstrates that modulation of the
nanoscale interface using nanofabrication and bioengineering
approaches with GFs and proteins provides a promising means
for further research and the development of physiologically
mimetic biomaterials for use in the lab and in the clinic. It is
apparent that the incorporation of synthetic ECM protein shapes,
proteins themselves and engineering their GF binding and cell
binding characteristics provide powerful tools for success in
these future directions.
Further, mimicking GF presentation allows control of
powerful GFs. We note that GFs are used widely in the clinic
but that their use remains controversial and thus their impact
limited. Typically, GFs are delivered at supraphysiological doses
due to rapid initial propagation from the implant site, for example
the current gold standard for in vivo bone repair is the INFUSE®
bone graft which delivers BMP-2 absorbed into a collagen I
sponge at a concentration of 1.5 mg/mL. Such high concentra-
tions of GF are not only costly, but also lead to severe off-target
effects, urging the FDA to release a public health notification of
life threatening complications associated with this device.100 We
have discussed material platforms that provide cell control by
mimicking the native microenvironment through nanoscale topog-
raphy, through engineered adhesion sites and through synergisticGF
presentation. Translation of these novel technologies will provide
better cell control and prevent the collateral damage being observed
with the current uses of GFs in the clinic.101
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